[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lucchi et al., 2005 - Google Patents

Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments

Lucchi et al., 2005

Document ID
6428393549624790800
Author
Lucchi L
Bergamini S
Iannone A
Perrone S
Stipo L
Olmeda F
Caruso F
Tomasi A
Albertazzi A
Publication year
Publication venue
Artificial organs

External Links

Snippet

An increased oxidative stress is now considered one of the major risk factors in chronic renal failure (CRF) patients that may be exacerbated by dialysis. It has been postulated that this increased oxidative stress might cause an augmented red blood cell (RBC) membrane lipid …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells

Similar Documents

Publication Publication Date Title
Lucchi et al. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments
Tbahriti et al. Effect of Different Stages of Chronic Kidney Disease and Renal Replacement Therapies on Oxidant‐Antioxidant Balance in Uremic Patients
Wilson Evaluation of vitamin C for adjuvant sepsis therapy
Morena et al. Overproduction of reactive oxygen species in end‐stage renal disease patients: A potential component of hemodialysis‐associated inflammation
Kandouz et al. Reduced protein bound uraemic toxins in vegetarian kidney failure patients treated by haemodiafiltration
Calvani et al. Carnitine replacement in end‐stage renal disease and hemodialysis
Lin et al. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase
Ward et al. Oxidant stress in hemodialysis patients: what are the determining factors?
Georgatzakou et al. Red blood cell abnormalities and the pathogenesis of anemia in end‐stage renal disease
Hörl Atherosclerosis and uremic retention solutes
Melo et al. Pruritus in hemodialysis patients: the problem remains
Mekki et al. Effect of hemodialysis and peritoneal dialysis on redox status in chronic renal failure patients: a comparative study
Dimitrijevic et al. How the duration period of erythropoietin treatment influences the oxidative status of hemodialysis patients
Sepe et al. Vitamin e-loaded membrane dialyzers reduce hemodialysis inflammaging
Tajbakhsh et al. Effect of hemodialysis on oxidants and antioxidant factors in chronic renal failure
Kitiyakara et al. Non-traditional cardiovascular disease risk factors in end-stage renal disease: oxidate stress and hyperhomocysteinemia
Colombo et al. Plasma protein carbonylation in haemodialysed patients: focus on diabetes and gender
Wratten et al. Hemolipodialysis attenuates oxidative stress and removes hydrophobic toxins
Sanaka et al. Randomized controlled open-label trial of vitamin E-bonded polysulfone dialyzer and erythropoiesis-stimulating agent response
Lucchi et al. Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress
Bibi et al. Compositional and Oxidative Analysis in the Saliva and Serum of Predialysis Chronic Kidney Disease Patients and End‐stage Renal Failure Patients on Peritoneal Dialysis
Oztas et al. Plasma protein oxidation is correlated positively with plasma iron levels and negatively with hemolysate zinc levels in sickle‐cell anemia patients
Menke et al. Antioxidant level and redox status of coenzyme Q10 in the plasma and blood cells of children with diabetes mellitus type 1
Bossola et al. Wishful thinking: the surprisingly sparse evidence for a relationship between oxidative stress and cardiovascular disease in hemodialysis patients
Montazerifar et al. Hemodialysis alters lipid profiles, total antioxidant capacity, and vitamins A, E, and C concentrations in humans